Sputnik V Vaccine

Regional News • Asia • India
Russia's Sputnik V Coronavirus vaccine approved in India
Russia's Sputnik V Coronavirus vaccine approved in India
Credit: Illustration: Pendect, Ashley Winkler.

India's Drug Controller General of India (DCGI) has approved use of Russia's Sputnik V Coronavirus vaccine. India is said to produce 750 million doses of the Russian vaccine.

"India, the world’s 2nd most populous nation, became the 60th country to register #SputnikV after positive results of local Phase 3 clinical study. Sputnik V is now authorized in 60 countries with a population of over 3 [billion] people," the Sputnik V official Twitter account wrote.

Regional News • Americas • South America
Argentina's President Alberto Fernández tests positive for Covid-19 in rapid test
Alberto Fernández receiving the first dose of the Covid-19 vaccine
Alberto Fernández receiving the first dose of the Covid-19 vaccine Credit: Esteban Collazo/Casa Rosada

The president of Argentina, Alberto Fernández, reported in the early hours of Saturday, April 3rd that he tested positive for Covid-19 after showing symptoms of the disease. Fernández had the two doses of the Russian Sputnik V Covid-19 vaccine.

"For everyone's information, I am physically fine and, although I wanted to end my birthday without this news, I am also in a good mood," posted the president of Argentina, who thanked for the messages of congratulations.

"We believe we are starting the second wave, with a sustained increase in cases, which causes concern," Health Minister Carla Vizzotti told a radio station on Friday.

Regional News • Asia • India
Russian Covid-19 vaccine Sputnik V to be produced by India Indian drugmaker

The Russian sovereign wealth fund (RDIF) has concluded another agreement for the production of the Corona vaccine Sputnik V in India. The agreement with the company Stelis from the Indian pharmaceutical group Strides provides for the production of at least 200 million doses of the vaccine from the third quarter of 2021, as the sovereign wealth fund announced on Friday. In November, RDIF had already signed an agreement with Indian group Hetero for 100 million doses annually.

In contrast to dozens of other countries, the Russian vaccine has not yet been approved in India, where clinical trials are still underway. At the same time, Moscow is counting on broadening the production of the vaccine due to the high international demand in the pandemic.

Regional News • Europe • Germany
Germany could imagine signing deal for Sputnik V shot, minister says
Sputnik V delivered to Argentina
Sputnik V delivered to Argentina Credit: Casa Rosada (Public Domain)

German Health Minister Jens Spahn said on Friday he would be in favour of signing a national supply deal with Russia for its Sputnik V vaccine for Covid-19.

"I can also well imagine that we conclude contracts - and conclude them quickly," Spahn told a weekly news conference, adding that Germany was in close contact with Russia on questions to do with the vaccine. A prerequisite, however, is that there is more detail on how many doses could be delivered, he said.

Regional News • Americas • Brazil
Brazil signs contract to receive 10 million doses of Sputnik V vaccine
Brazil signs contract to receive 10 million doses of Sputnik V vaccine
Credit: Illustration: Pendect, Ashley Winkler.

The Brazilian Ministry of Health signed on Friday a contract to receive 10 million doses of the Sputnik V vaccine, developed by Russia's Gamaleya Institute.

According to a federal law sanctioned at the beginning of the pandemic last year, Anvisa has 72 hours to decide whether or not to validate the registration of a Covid-19 vaccine granted by one of the national health agencies of the United States, the European Union, Japan and China - Sputnik was approved in Russia and also in Argentina.

Regional News • Europe
Biopharma company to produce Russian Sputnik V vaccine in Italy
Biopharma company to produce Russian Sputnik V vaccine in Italy
Credit: Illustration: Pendect, Ashley Winkler. (Creative Commons Attribution ShareAlike 4.0)

The Swiss biotech company Adienne Pharma & Biotech signed an agreement to manufacture the Sputnik V vaccine at its production site in the Milan region, said Antonio Francesco Di Naro, founder and president of the company.

The deal comes as Prime Minister Mario Draghi pledged to speed up Italy's fledgeling vaccination campaign amid a new rise in infections from the disease that's led to more than 100,000 fatalities in the country.

European Commission President Ursula von der Leyen on Monday lashed out at manufacturers for failing to uphold their commitments as countries in Europe struggle to step up the pace of inoculations.

Regional News • Europe • European Union
EMA urges EU not to grant emergency authorization for Russian Covid-19 vaccine
EMA urges EU not to grant emergency authorization for Russian Covid-19 vaccine
Credit: Mos.ru, via Wikimedia Commons (Creative Commons Attribution 4.0)

An official of the European Medicines Agency (EMA) is cautioning the European Union to hold back on granting emergency authorization for Sputnik V, Russia's Covid-19 vaccine until its effectiveness has been reviewed.

“We need documents that we can review. We also don’t at the moment have data...about vaccinated people. It is unknown. That’s why I would urgently advise against giving a national emergency authorization,” EMA managing board head Christa Wirthumer-Hoche said. “We can have Sputnik V on the market here in future when the appropriate data have been reviewed. The rolling review has begun now at EMA.”

Health
Sputnik V vaccine is 91.6% effective
Sputnik V vaccine is 91.6% effective
Credit: Illustration: Pendect, Ashley Winkler.

According to The Lancet results on Tuesday, the Russian Sputnik V vaccine is 91.6% effective against symptomatic Covid-19. Independent experts said the publishing allayed transparency concerns over the jab, that is already being used in Russia and Argentina.

The effectiveness calculation was based on the analysis of data of 19,866 volunteers. In volunteers aged above 60, the efficacy rate was 91.8 per cent. Among adverse events, 94 per cent were mild and included flu-like symptoms, reactions in the vaccine site, headache and asthenia. However, no serious adverse events were reported.

Health
Putin does not want to be vaccinated with Russia's "safe" Covid-19 vaccine
Putin does not want to be vaccinated with Russia's "safe" Covid-19 vaccine
Credit: Kremlin.ru / via Wikimedia Commons (Creative Commons Attribution 4.0)

According to his spokesperson, Russian President Vladimir Putin does not want to be vaccinated with the Russian "Sputnik V" vaccine. Even though Putin recently appraised the world's vaccine at the G20 summit as safe and effective, his spokesperson said that as head of state he could not participate in a vaccination campaign as a "volunteer". Kremlin spokesman Dmitry Peskov said on Tuesday that tThe president cannot take an uncertified vaccine".